Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.6360
+0.0136 (2.19%)
Nov 6, 2026, 4:00 PM EST - Market closed
Standard BioTools Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 267.49 | 120.86 | 166.73 | 51.7 | 81.31 | 28.45 |
Short-Term Investments | 193.62 | 66.71 | 126.15 | 63.19 | 84.48 | - |
Cash & Short-Term Investments | 461.11 | 187.58 | 292.87 | 114.9 | 165.78 | 28.45 |
Cash Growth | 136.59% | -35.95% | 154.91% | -30.70% | 482.70% | -58.48% |
Receivables | 12.98 | 13.43 | 14.74 | 19.66 | 17.28 | 18.32 |
Inventory | 17.62 | 19.98 | 20.74 | 20.53 | 21.47 | 20.83 |
Prepaid Expenses | 5.59 | 4.87 | 4.56 | 3.13 | 4.28 | 4.45 |
Restricted Cash | - | - | - | - | - | 0.02 |
Other Current Assets | - | 228.41 | 42.96 | - | - | - |
Total Current Assets | 497.3 | 454.26 | 375.88 | 158.22 | 208.82 | 72.07 |
Property, Plant & Equipment | 36.32 | 46.01 | 49.34 | 54.85 | 59.54 | 65.15 |
Long-Term Investments | 98.24 | 25.7 | - | - | - | - |
Goodwill | - | - | - | 106.32 | 106.25 | 106.38 |
Other Intangible Assets | - | - | - | 1.4 | 13.18 | 29.18 |
Long-Term Deferred Tax Assets | 0.27 | 38.63 | 0.14 | - | 0.23 | 0.18 |
Other Long-Term Assets | 3.19 | 3.15 | 186.98 | 2.29 | 2.3 | 2.25 |
Total Assets | 635.33 | 567.75 | 612.35 | 323.07 | 390.31 | 275.21 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.45 | 5.41 | 5.05 | 9.24 | 7.91 | 10.6 |
Accrued Expenses | 30.44 | 25.24 | 16.75 | 16.09 | 7.52 | 13.59 |
Short-Term Debt | - | - | - | - | - | 6.84 |
Current Portion of Long-Term Debt | - | - | - | 59.53 | 2.08 | - |
Current Portion of Leases | 5.69 | 5.49 | 4.81 | 4.32 | 3.68 | 3.05 |
Current Income Taxes Payable | - | - | - | - | 1.44 | - |
Current Unearned Revenue | 11.44 | 42 | 13.8 | 15.22 | 14.44 | 15.48 |
Other Current Liabilities | - | 30.17 | 25.49 | 4.93 | 6.37 | - |
Total Current Liabilities | 51.02 | 108.31 | 65.9 | 109.33 | 43.44 | 49.57 |
Long-Term Debt | 0.3 | 0.3 | 0.3 | 3.98 | 62.81 | 64.21 |
Long-Term Leases | 20.84 | 25.04 | 25.59 | 30.37 | 34.08 | 37.55 |
Long-Term Unearned Revenue | 5.47 | 7.79 | 39.92 | 14.28 | 18.18 | 24.08 |
Long-Term Deferred Tax Liabilities | 0.82 | 0.81 | 1.08 | 0.84 | 1.06 | 4.33 |
Other Long-Term Liabilities | 1.12 | 1.22 | 7.84 | 1.07 | 0.96 | 0.88 |
Total Liabilities | 79.58 | 143.46 | 140.62 | 159.87 | 160.52 | 180.62 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.41 | 0.4 | 0.4 | 0.08 | 0.08 | 0.08 |
Additional Paid-In Capital | 1,748 | 1,732 | 1,702 | 860.82 | 847.01 | 831.42 |
Retained Earnings | -1,147 | -1,261 | -1,186 | -1,001 | -926.1 | -736 |
Treasury Stock | -46.47 | -46.47 | -46.47 | -5.98 | -0.56 | - |
Comprehensive Income & Other | 0.35 | -1.49 | 1.23 | -2.22 | -1.9 | -0.91 |
Total Common Equity | 555.75 | 424.29 | 471.72 | -148.05 | -81.47 | 94.6 |
Shareholders' Equity | 555.75 | 424.29 | 471.72 | 163.2 | 229.79 | 94.6 |
Total Liabilities & Equity | 635.33 | 567.75 | 612.35 | 323.07 | 390.31 | 275.21 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 26.83 | 30.83 | 30.7 | 98.21 | 102.66 | 111.65 |
Net Cash (Debt) | 434.28 | 156.75 | 262.18 | 16.69 | 63.13 | -83.2 |
Net Cash Growth | 159.25% | -40.21% | 1471.35% | -73.57% | - | - |
Net Cash Per Share | 1.12 | 0.41 | 0.74 | 0.21 | 0.81 | -1.10 |
Filing Date Shares Outstanding | 394.79 | 390.07 | 378.99 | 290.12 | 79.06 | 77.2 |
Total Common Shares Outstanding | 394.67 | 386.38 | 377.53 | 80.23 | 79.48 | 76.92 |
Working Capital | 446.28 | 345.96 | 309.99 | 48.89 | 165.37 | 22.5 |
Book Value Per Share | 1.41 | 1.10 | 1.25 | -1.85 | -1.02 | 1.23 |
Tangible Book Value | 555.75 | 424.29 | 471.72 | -255.77 | -200.9 | -40.97 |
Tangible Book Value Per Share | 1.41 | 1.10 | 1.25 | -3.19 | -2.53 | -0.53 |
Buildings | - | - | - | 1.76 | 1.71 | - |
Machinery | - | 39.37 | 43.26 | 41.8 | 39.12 | 38.09 |
Construction In Progress | - | 0.9 | 6.03 | 2.33 | 1.61 | 4.55 |
Leasehold Improvements | - | 14.05 | 13.75 | 13.79 | 12.23 | 12.1 |